Commonwealth Equity Services’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Commonwealth Equity Services’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-44,720	Closed	-$4K	–	2410
2016 Q3	$4K	Buy	44,720 +1,220	+3%	+$266	﹤0.01%	2249
2016 Q2	$16K	Hold	43,500	–	–	﹤0.01%	2212
2016 Q1	$17K	Buy	43,500 +1,000	+2%	+$412	﹤0.01%	2174
2015 Q4	$17K	Hold	42,500	–	–	﹤0.01%	2155
2015 Q3	$24K	Sell	42,500 -40,000	-48%	-$20.5K	﹤0.01%	2101
2015 Q2	$45K	Buy	82,500 +2,000	+2%	+$1.63K	﹤0.01%	2137
2015 Q1	$66K	Hold	80,500	–	–	﹤0.01%	2098
2014 Q4	$64K	Sell	80,500 -1,000	-1%	-$914	﹤0.01%	2015
2014 Q3	$83K	Hold	81,500	–	–	﹤0.01%	1979
2014 Q2	$70K	Buy	+81,500	New	+$97.7K	﹤0.01%	1967

Other funds holding PVCT

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Home Federal Bank of Tennessee Knoxville, Tennessee $465M AUM 18.18% 1-Year Est. Return

Commonwealth Equity Services's PVCT Position: Q4 2016 in Review

Commonwealth Equity Services sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 44,720 shares — an estimated $4K sold.

Commonwealth Equity Services first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $83K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Commonwealth Equity Services reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Commonwealth Equity Services sold 44,720 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $4K.
Commonwealth Equity Services first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
Commonwealth Equity Services's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $83K in Q3 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.